Monitoring peripheral blood leukocyte and immune responses in health and disease
监测健康和疾病中的外周血白细胞和免疫反应
基本信息
- 批准号:8936128
- 负责人:
- 金额:$ 37.51万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-06-23 至 2020-05-31
- 项目状态:已结题
- 来源:
- 关键词:AcuteAddressAnemiaBiological AssayBiomedical EngineeringBloodBlood PlateletsBlood TestsBlood VolumeCellsChronicClinicalClinical MedicineClinical assessmentsComplete Blood CountComplexCoupledDataDevelopmentDiagnosticDiagnostic testsDifferential white blood cell count procedureDiseaseDoseEngineeringErythrocytesFractionationHealthHospitalsHumanHypersensitivityImmuneImmune responseImmunologic MonitoringImmunosuppressive AgentsInfectionInflammatoryInflammatory ResponseLabelLaboratoriesLeukocytesLymphocyte FunctionMalignant NeoplasmsMeasurementMeasuresMedicalMedicineMethodsMicrofluidic MicrochipsMicrofluidicsMonitorMorbidity - disease rateOpportunistic InfectionsPatientsPeripheralPlasmaPropertyRegimenRoutine Diagnostic TestsSamplingSecondary toSystemTestingTherapeuticTransplantationVenousWhite Blood Cell Count procedureWhole Bloodadaptive immunitybasecell typecellular targetingclinical practicecostdesignimmune functionimmunoregulationlong term hospitalizationmilliliterneutrophilnovelnovel strategiesperipheral bloodpublic health relevanceresearch studyresponse
项目摘要
DESCRIPTION (provided by applicant): The proposed experiments will test the hypothesis: The separation of leukocytes by their intrinsic properties using Dean Flow Fractionation will enable analyses of innate and adaptive immune responses in microliter quantities of whole blood. Acute and chronic inflammatory responses are integral to the clinical expression of many diseases, yet routine clinical assessment of immune function is based solely on leukocyte count. This is typically measured with a complete blood count and leukocyte differential count. In current clinical practice, critical clinical decisions regarding immune modulation are made based on the count of leukocytes and leukocyte subclasses without assessment of leukocyte function. In addition, the measurement of a peripheral venous complete blood count uses 3-5 mL. Based on the significant blood volume required for the complete blood count and other routine laboratory testing, patients can develop iatrogenic anemia. There is a critical need to develop assays that enable assessment of immune function and require significantly smaller volumes of blood. In preliminary results, we have developed an inertial microfluidic approach to selectively separate diverse cellular targets that is based on non-labeled, cell type specific physical features. From peripheral venous blood, this new approach can separate leukocytes from erythrocytes and platelets, leukocyte subclasses and distinguish activated neutrophils from unactivated cells by tandem iso-dielectric separation. This multi-functional, extracorporeal separation system is high throughput and capable of preparatory separation of leukocytes prior to coupled analyses of systemic and cellular immune function. To address our hypothesis, two specific aims are proposed: 1. Design microliter scale preparatory inertial microfluidic separation
of leukocytes in peripheral blood; 2. Determine microliter scale assays of systemic and cell-based immune function. Recent advances in high-throughput microfluidic engineering enable this project, paving the way for a new approach to complex immune monitoring.
描述(由申请人提供):拟议的实验将检验假设:使用Dean Flow Fractionation根据白细胞的固有属性分离白细胞将能够分析微升全血中的先天和获得性免疫反应。急性和慢性炎症反应是许多疾病临床表现的组成部分,但常规的临床免疫功能评估仅基于白细胞计数。这通常是通过完整的血细胞计数和白细胞分类计数来衡量的。在目前的临床实践中,关于免疫调节的关键临床决策是基于白细胞和白细胞亚类的计数,而不是评估白细胞功能。此外,外周静脉全血细胞计数的测量使用3-5毫升。根据完成血细胞计数和其他常规实验室检测所需的大量血量,患者可能会患上医源性贫血。迫切需要开发能够评估免疫功能的分析方法,并且需要的血量要少得多。在初步结果中,我们开发了一种惯性微流控方法,基于非标记的细胞类型特定的物理特征选择性地分离不同的细胞靶点。这种新方法可以从外周静脉血中分离白细胞和红细胞、血小板、白细胞亚类,并通过串联等电分离来区分激活的中性粒细胞和未激活的细胞。这种多功能的体外分离系统是高通量的,能够在系统和细胞免疫功能的耦合分析之前对白细胞进行预备分离。为了解决我们的假设,提出了两个具体的目标:1.设计微升规模的惯性微流控分离
检测外周血中的白细胞;2.测定系统免疫功能和细胞免疫功能的微升。高通量微流控工程的最新进展使这一项目成为可能,为复杂免疫监测的新方法铺平了道路。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(2)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Bruce D Levy其他文献
Clinical problem-solving. Whistling in the dark.
临床问题解决。
- DOI:
10.1056/nejmcps1106363 - 发表时间:
2012 - 期刊:
- 影响因子:0
- 作者:
Daniel A Solomon;Christopher H Fanta;Bruce D Levy;Joseph Loscalzo - 通讯作者:
Joseph Loscalzo
Development of an asthma health-care burden score as a measure of severity and predictor of remission in SARP III and U-BIOPRED: results from two major longitudinal asthma cohorts
开发哮喘保健负担评分作为 SARP III 和 U-BIOPRED 中严重程度的衡量指标和缓解预测因子:来自两个主要纵向哮喘队列的结果
- DOI:
10.1016/s2213-2600(24)00250-9 - 发表时间:
2025-01-01 - 期刊:
- 影响因子:32.800
- 作者:
Joe G Zein;Nazanin Zounemat-Kermani;Ian M Adcock;Bo Hu;Amy Attaway;Mario Castro;Sven-Erik Dahlén;Loren C Denlinger;Serpil C Erzurum;John V Fahy;Benjamin Gaston;Annette T Hastie;Elliot Israel;Nizar N Jarjour;Bruce D Levy;David T Mauger;Wendy Moore;Michael C Peters;Kaharu Sumino;Elizabeth Townsend;Eugene R Bleecker - 通讯作者:
Eugene R Bleecker
Bruce D Levy的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Bruce D Levy', 18)}}的其他基金
EPHEDRA: Enhanced PHthisic by Environmental Disruptors of Resolution Agonists
麻黄:通过消解激动剂的环境干扰剂增强肺结核
- 批准号:
10662073 - 财政年份:2022
- 资助金额:
$ 37.51万 - 项目类别:
Monitoring pro-resolving leukocyte responses in peripheral blood predicts clinical severity during sepsis
监测外周血中促溶解白细胞反应可预测脓毒症期间的临床严重程度
- 批准号:
10354958 - 财政年份:2022
- 资助金额:
$ 37.51万 - 项目类别:
Monitoring pro-resolving leukocyte responses in peripheral blood predicts clinical severity during sepsis
监测外周血中促溶解白细胞反应可预测脓毒症期间的临床严重程度
- 批准号:
10541851 - 财政年份:2022
- 资助金额:
$ 37.51万 - 项目类别:
Monitoring peripheral blood leukocyte and immune responses in health and disease
监测健康和疾病中的外周血白细胞和免疫反应
- 批准号:
9096011 - 财政年份:2015
- 资助金额:
$ 37.51万 - 项目类别:
Project 2 :Specialized Pro-Resolving Lipid Mediators
项目 2:专业化脂质调节剂
- 批准号:
8449234 - 财政年份:2013
- 资助金额:
$ 37.51万 - 项目类别:
Project 2 :Specialized Pro-Resolving Lipid Mediators
项目 2:专业化脂质调节剂
- 批准号:
8375337 - 财政年份:2012
- 资助金额:
$ 37.51万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 37.51万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 37.51万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 37.51万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 37.51万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 37.51万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 37.51万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 37.51万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 37.51万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 37.51万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 37.51万 - 项目类别:
Research Grant














{{item.name}}会员




